| ²é¿´: 1598 | »Ø¸´: 3 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
mengjing12гæ (³õÈëÎÄ̳)
|
[ÇóÖú]
ͶÁËÆªSCI£¬Éó¸åÈ˸øÁ˼¸ÌõÒâ¼û£¬»¹Íû´ó¼Ò°ïÎÒ·ÖÎöһϠÒÑÓÐ2È˲ÎÓë
|
|
|
ÔÚ¡°Journal of Cardiovascular Pharmacology¡±Í¶ÁËһƪÎÄÕ£¬ÐÞ¸ÄÒâ¼ûÖ»ÓÐÒ»¸öreviewerµÄ¡£Òâ¼ûÈçÏ£¬ÏëÈôó¼Ò°ïÎÒ·ÖÎöһϡ£ Reviewer #1: This is a beginning of dissection of the pathway involved in the sympathetic nervous system's role in fibrotic expansion in the heart. There are some components that could be added to strengthen the conclusions made here.£¨´Ë´¦µÄÒâ˼ÊÇÈò¹³äʵÑéô£¿¾ßÌåҲû˵²¹³äÄÄ·½ÃæµÄʵÑé°¡£¬¸Ð¾õºÜÃÔ㣩 Additionally, THE PAPER MUST BE REWRITTEN BY A NATIVE ENGLISH SPEAKER FOR PORPER SYNTAX AND GRAMMAR. 1. A study by Hirota et al in lung recently came out looking at lung fibroblasts. It would be interesting to have this discussed in the context of the work you have done in the heart. (Hirota et al, Gene expression profiling of lung myofibroblasts reveals the anti-fibrotic effects of cyclosporine. Tohoku J. of Exp Med 233(4) pg 283-293, 2014).£¨´Ë´¦µÄÒâ˼ÊÇÈÃÒýÓôËÎÄÏ×£¬ÎÒÒѾÒýÓÃÁË£¬µ«ÊÇÔڻظ´Òâ¼ûʱ¸ÃÔõô¿ä½±´ËÎÄÕ£¿×îºÃÄܸø¸öÓ¢ÎİæµÄÄ£°æ£¬±¾ÈËÓ¢Óﲻ̫ºÃ£© 2. AKT, MAPK and ERK have all been shown to be involved in fibrosis and myofibroblast activation. Are they affected by either NE or by inhibition through one of the drugs tested here? ´Ë´¦Ìá¼°µÄAKT, MAPK and ERKÔÚNE´Ì¼¤ÊÇÊÇÓз´Ó¦µÄ£¬ÕâÓÐÎÄÏ×±¨µÀ£¬ÎÒûÓмì²â£¬ÄÇôÎһظ´Òâ¼ûʱÊDz»ÊÇÒª°ÑÈ˼ҵÄÎÄÏ×ÁгöÀ´£¿½âÊÍ×Ô¼ºÃ»ÓÐ×öµÄÔÒò£¿ 3. Pannexin's have been shown to be important in activation of myofibroblasts in the heart. Are there changes in pannexins in this study? ´Ë´¦Ìá¼°µÄPannexin¸úÎÒµÄÑо¿Ã»ÓÐÌ«´ó¹ØÏµ£¬ÎÒûÓмì²â´ËÖ¸±ê¡£ÄÇôÎÒ¸ÃÔõô»Ø¸´Éó¸åÈË£¿ |
» ²ÂÄãϲ»¶
085600²ÄÁÏÓ뻯¹¤329·ÖÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
283Çóµ÷¼Á 086004¿¼Ó¢¶þÊý¶þ
ÒѾÓÐ5È˻ظ´
ÉúÎïѧµ÷¼Á
ÒѾÓÐ5È˻ظ´
ũѧ0904 312Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
¸´ÊÔµ÷¼Á
ÒѾÓÐ9È˻ظ´
²ÄÁÏÓ뻯¹¤µ÷¼Á
ÒѾÓÐ35È˻ظ´
µ÷¼ÁÇóÊÕÁô
ÒѾÓÐ10È˻ظ´
Ò»Ö¾Ô¸¹þ¹¤´ó 085600 277 12²Ä¿Æ»ùÇóµ÷¼Á
ÒѾÓÐ18È˻ظ´
0831ÉúÒ½¹¤µÚÒ»ÂÖµ÷¼Áʧ°ÜÇóÖú
ÒѾÓÐ9È˻ظ´
ÉúÎïѧ308Çóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©
ÒѾÓÐ6È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
SCIÍÆ¼öÉó¸åÈ˶¼ÔõôѡÔñ£¿
ÒѾÓÐ6È˻ظ´
Çë´ó¼Ò°ïÎÒ·ÖÎöÏÂÉó¸åÒâ¼û
ÒѾÓÐ18È˻ظ´
sciÉó¸åÒâ¼ûÇóÖú£¿
ÒѾÓÐ13È˻ظ´
ÎÄÕµÄÉó¸åÒâ¼û»ØÀ´ÁË£¬¾õµÃÉó¸åÈËÒâ¼ûÓÐÎÊÌ⣬Ïëдargue£¬Çë½ÌÔõôдargue
ÒѾÓÐ9È˻ظ´
SCIÉó¸åÒâ¼û½â¶Á
ÒѾÓÐ7È˻ظ´
µÚÒ»´ÎͶSCI£¬±»¾Ü£¬Éó¸åÒâ¼ûÇóµãÆÀ
ÒѾÓÐ5È˻ظ´
SCIÂÛÎÄÒ»Éó»ØÀ´Éó¸åÈËÒâ¼ûÏà²î·Ç³£´óÈçºÎÐ޸ģ¿
ÒѾÓÐ19È˻ظ´
´ó¼Ò°ï¿´Ò»ÏÂÕâ¸öÉó¸åÒâ¼û¼¬ÊÖ²»£¬Ð»Ð»ÁË¡£
ÒѾÓÐ22È˻ظ´
SCIÉó¸åºó£¬²»Ö¹ÓÐÉó¸åÒâ¼û»¹ÓÐÒ»¸ö´øÅú×¢µÄpdfÎĵµ
ÒѾÓÐ17È˻ظ´
Ͷ¸åSCI£¬Éó¸åÒâ¼ûÇóÖú
ÒѾÓÐ8È˻ظ´
SCI±à¼Ò»¶¨»áÕÒ×Ô¼ºÍƼöµÄÉó¸åÈËÂð
ÒѾÓÐ22È˻ظ´
¸ÕÊÕµ½SCIÆÚ¿¯µÄÉó¸åÒâ¼û£¬ÈçºÎ»Ø´ðÉó¸åÈË£¿
ÒѾÓÐ23È˻ظ´
sciÈçºÎ»Ø¸´Éó¸åÒâ¼û£¬ÓÈÆäÊǸĸñʽµÄÉó¸åÒâ¼û£¿
ÒѾÓÐ8È˻ظ´
SCIÉó¸åÈËÏ£ÍûÔö¼ÓÄÚÈÝ£¬Èç²»Ôö¼Ó»á±»¾Ü¸åô£¿
ÒѾÓÐ22È˻ظ´
ĿǰһƪSCIÂÛÎÄÕýÔÚÉó¸åÖУ¬µ«ÏÖÔÚ·¢ÏÖÁËÎÄÕÂÖеÄһЩÎÊÌ⣬Ôõô°ì
ÒѾÓÐ41È˻ظ´
[ÇóÖú] sciÂÛÎÄrevise, ÆäÖÐÒ»¸ö¾Ü¸åµÄÉó¸åÈËÒâ¼û¸ÃÈçºÎ»Ø¸´£¿
ÒѾÓÐ14È˻ظ´
SCIÉó¸åÒâ¼û»ØÀ´ÁË£¬±à¼¸øµÄmoderate revision£¬Âé·³´ó¼Ò°ï·ÖÎöһϣ¬ÓÐBB
ÒѾÓÐ28È˻ظ´
SCIÎÄÕµÄÉó¸åÒâ¼û£¬Â¼Óýá¹ûÊÇÖ»¸ø×¢²áͶ¸åϵͳµÄÓÊÏä·¢Âð£¬Ð»Ð»£¡
ÒѾÓÐ14È˻ظ´
synthetic metals Ͷ¸å£¬Éó¸åÒâ¼û£¬ Çë¸÷λ°ïæ·ÖÎöһϣ¡
ÒѾÓÐ6È˻ظ´
ÓÃÉó¸åÈ˵ĽǶȿ´SCIд×÷¹Ø¼üÊ®´óÒªµã£¨·ÖÏí£©
ÒѾÓÐ50È˻ظ´
ͶSCI´óÐÞ£¬Éó¸åÈË2¸öͬÒâÒ»¸ö¾Ü¸å
ÒѾÓÐ18È˻ظ´
geyaolove8
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 53 (³õÖÐÉú)
- ½ð±Ò: 2527
- É¢½ð: 2935
- ºì»¨: 54
- Ìû×Ó: 2588
- ÔÚÏß: 321.7Сʱ
- ³æºÅ: 2416371
- ×¢²á: 2013-04-13
- ÐÔ±ð: GG
- רҵ: ÓîÖæÑ§

3Â¥2015-01-08 14:11:13
ssssllllnnnn
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
Translator and Proofreader
- Ó¦Öú: 452 (˶ʿ)
- ½ð±Ò: 31580.9
- ºì»¨: 100
- Ìû×Ó: 7681
- ÔÚÏß: 19966.6Сʱ
- ³æºÅ: 3328089
- ×¢²á: 2014-07-17
- רҵ: Ö×Áö·¢Éú
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
mengjing12: ½ð±Ò+5, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2015-01-12 22:01:54
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
mengjing12: ½ð±Ò+5, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2015-01-12 22:01:54
|
ûÓÐÃ÷È·Èò¹ÊµÑ飬ËùÒԾͲ»Óÿ¼ÂÇÕâ¸öÎÊÌâÁË£¬ÄÇ´Ë´¦ºÎÒ⣿ÎÒµÄÀí½âÊÇÕë¶ÔÏÂÃæµÄ1¡¢2¡¢3¶øÑԵġ£ ¶ÔÓÚÏÂÃæµÄ1¡¢2¡¢3£¬Æäʵ²»Äѻشð¡£Ö®ËùÒÔ»áÌá³öÕâÈýÌõ£¬ÌرðÊÇǰÁ½Ìõ£¬ÊÇÒòΪÄã×Ô¼ºµ±³õûÓжԽá¹û½áÂÛÕ¹¿ª½ÏΪÉîÈëµÄÌÖÂÛ£¬¿ÉÄܽöÊÇÎÞ¹ØÍ´Ñ÷µÄ·º·º¶øÑÔ¡£ ±ÈÈç1¡¢Éó¸åÈËÌá³öÕâÌõ²»ÊÇ˵ÄãÒýÓÃÓë·ñ£¬¶øÊǽá¹û¸ÃÎÄÏ×ÓëÄã×Ô¼ºµÄ½á¹û½øÐÐÉîÈëµÄÌÖÂÛ¡£ÖÁÓÚ2£¬Õâ¸öÎÊÌâµÄÌá³öÒ²ÊÇÔ´ÓÚÄãûÓÐ˵Ã÷¸Ã˵Ã÷µÄ½áÂÛ£¨NEµÄ×÷Óã©£¬ÐÞ¸Äʱ¾¡¿ÉÄÜÏêϸµÄ²¹ÉϾÍÐС£ ¶ÔÓÚµÚÈýµã£¬Ã»Óвâ¾ÍÊÇûÓв⡣ÕâûÓÐʲô£¬Ö±½Ó¸æËßËûÃǾÍÐС£ÊÂʵÊÇ£¬²ÎÓëÈκÎÉúÀí¡¢²¡Àí¹ý³Ì£¨ÄãÕâÀïÊÇmyofibroblast activation£©µÄpathwayÓкܶ࣬ÿһpathwayÖÐÓÖÓÐÐíÐí¶à¶àµÄfactors£¬²»¿ÉÄÜҲûÓбØÒª¶ÔËùÒÔÓÐ×÷ÓõĶ¼È¥×öÒ»±é¡£»Ø´ðʱֻҪÁ˽âÐÔµÄÌá³ö¸öÈË¿´·¨¾ÍºÃ¡£ Ó¢Óﲿ·Öµ±È»ÐèÒªºÃºÃ¸Ä£¬Õâ¿ÉÄÜÒ²ÊDz»ÄܽøÐÐϸÖÂÌÖÂÛµÄÒ»¸öÔÒò¡£ Good luck£¬ btw |
2Â¥2015-01-08 12:46:54
mengjing12
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 18.3
- Ìû×Ó: 4
- ÔÚÏß: 2.2Сʱ
- ³æºÅ: 3000316
- ×¢²á: 2014-02-27
- רҵ: ÐÄÁ¦Ë¥½ß
4Â¥2015-01-08 17:20:25













»Ø¸´´ËÂ¥